AN2 Therapeutics (ANTX) Shares Outstanding (Entity) (2021 - 2026)
AN2 Therapeutics' Shares Outstanding (Entity) was 36.31 million in Q2 2026, up 32.6% from 27.38 million a year earlier and up 0.9% from the prior quarter.
Powered by 
Analysis
AN2 Therapeutics (ANTX) Shares Outstanding (Entity) (2021 - 2026) Analysis & Trends
For FY2025, Shares Outstanding (Entity) at AN2 Therapeutics came in at 27.41 million, down 8.4% from FY2024.
- Shares Outstanding (Entity) shows a four-year compound annual growth rate of 78.0% (FY2021 to FY2025).
- In earlier years, Shares Outstanding (Entity) was 29.92 million in FY2024 (+26.8%), 23.6 million in FY2023 (+53.8%), 15.34 million in FY2022 (+461.8%) and 2.73 million in FY2021.
- The Q2 2026 figure marks the highest quarterly Shares Outstanding (Entity) in data going back to Q1 2021.
- Compared with a year earlier, Shares Outstanding (Entity) was higher in five of the last eight quarters, with growth averaging 6.9%.
- The best year-over-year quarter for Shares Outstanding (Entity) over five years was Q3 2022 (growth of 610.6%); the worst was Q4 2025 (a decline of 8.4%).
- Per Business Quant data, ANTX's Shares Outstanding (Entity) in the three quarters before Q2 2026 was 35.99 million (Q1 2026), 27.41 million (Q4 2025) and 27.37 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 540.60 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 253.35 Mn |
| 10 | AN2 Therapeutics | 193.16 Mn | 193.16 Mn | - | 36.31 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 36.31 Mn |
| Mar 31, 2026 | 35.99 Mn |
| Dec 31, 2025 | 27.41 Mn |
| Sep 30, 2025 | 27.37 Mn |
| Jun 30, 2025 | 27.38 Mn |
| Mar 31, 2025 | 30.14 Mn |
| Dec 31, 2024 | 29.92 Mn |
| Sep 30, 2024 | 29.87 Mn |
| Jun 30, 2024 | 29.83 Mn |
| Mar 31, 2024 | 29.82 Mn |
| Dec 31, 2023 | 23.60 Mn |
| Sep 30, 2023 | 29.74 Mn |
| Jun 30, 2023 | 21.93 Mn |
| Mar 31, 2023 | 19.43 Mn |
| Dec 31, 2022 | 15.34 Mn |
| Sep 30, 2022 | 19.40 Mn |
| Jun 30, 2022 | 19.40 Mn |
| Mar 31, 2022 | 3.18 Mn |
| Dec 31, 2021 | 2.73 Mn |
| Sep 30, 2021 | 2.73 Mn |
API Access
AN2 Therapeutics Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=ANTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "ANTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=ANTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();